Those results will be critical for determining whether Foundayo earns the same cardiovascular risk-reduction indications that have been granted to injectable semaglutide
Batth IS, Mitra A, Manier S, Ghobrial IM, Menter D, Kopetz S , Li S
When to seek medical attention: Severe or persistent abdominal pain (stop medication and seek urgent carepotential pancreatitis) Persistent nausea or vomiting affecting hydration or nutrition Signs of gallbladder disease (right upper quadrant pain) Symptoms of hypoglycaemia if taking other diabetes medications No weight loss after 3 months at maintenance dose Regular monitoring, including weight, waist circumference, blood pressure, and metabolic parameters, should be conducted throughout treatment to assess efficacy and safety
The DMA said the findings were strong enough that there should be an investigation into whether or not NAION should be listed as a possible adverse event when taking Ozempic
This article was produced under Drug Discovery News AI Editorial Guidelines .
This prevents excessive collagen buildup, reducing thickness
